Identification and functional characterization of two novel NPR2 mutations in Japanese patients with short stature.
暂无分享,去创建一个
T. Ogata | Yoshiya Ito | Toshiaki Tanaka | T. Hasegawa | Satoshi Narumi | T. Mukai | S. Yokoya | N. Amano | Y. Ito | S. Narumi
[1] 三浦 弘司,et al. An overgrowth disorder associated with excessive production of cGMP due to a gain-of-function mutation of the natriuretic peptide receptor 2 gene , 2013 .
[2] A. Uitterlinden,et al. An activating mutation in the kinase homology domain of the natriuretic peptide receptor-2 causes extremely tall stature without skeletal deformities. , 2013, The Journal of clinical endocrinology and metabolism.
[3] H. Yoshikawa,et al. An Overgrowth Disorder Associated with Excessive Production of cGMP Due to a Gain-of-Function Mutation of the Natriuretic Peptide Receptor 2 Gene , 2012, PloS one.
[4] W. Ahmad,et al. Novel mutations in natriuretic peptide receptor-2 gene underlie acromesomelic dysplasia, type maroteaux , 2012, BMC Medical Genetics.
[5] T. Ogata,et al. Identification and functional analysis of novel human growth hormone secretagogue receptor (GHSR) gene mutations in Japanese subjects with short stature. , 2011, The Journal of clinical endocrinology and metabolism.
[6] K. Nakao,et al. Translational research of C-type natriuretic peptide (CNP) into skeletal dysplasias. , 2010, Endocrine journal.
[7] L. Al-Gazali,et al. Defective cellular trafficking of missense NPR-B mutants is the major mechanism underlying acromesomelic dysplasia-type Maroteaux. , 2008, Human molecular genetics.
[8] Jeffrey L. Brodsky,et al. One step at a time: endoplasmic reticulum-associated degradation , 2008, Nature Reviews Molecular Cell Biology.
[9] W. Wilcox,et al. C-natriuretic peptide: an important regulator of cartilage. , 2007, Molecular genetics and metabolism.
[10] Y. Kamei,et al. Intact kinase homology domain of natriuretic peptide receptor-B is essential for skeletal development. , 2007, The Journal of clinical endocrinology and metabolism.
[11] T. Tsuji,et al. Short-limbed dwarfism: slw is a new allele of Npr2 causing chondrodysplasia. , 2007, The Journal of heredity.
[12] R. Olney. C-type natriuretic peptide in growth: a new paradigm. , 2006, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[13] M. Warman,et al. Heterozygous mutations in natriuretic peptide receptor-B (NPR2) are associated with short stature. , 2006, The Journal of clinical endocrinology and metabolism.
[14] Guangyu Wu,et al. Cell-surface targeting of alpha2-adrenergic receptors -- inhibition by a transport deficient mutant through dimerization. , 2006, Cellular signalling.
[15] E. Martínez-Alonso,et al. Dimerization of the human melanocortin 1 receptor: functional consequences and dominant-negative effects. , 2006, The Journal of investigative dermatology.
[16] K. Misono,et al. Crystal Structure of Hormone-bound Atrial Natriuretic Peptide Receptor Extracellular Domain , 2004, Journal of Biological Chemistry.
[17] S. Brothers,et al. Human loss-of-function gonadotropin-releasing hormone receptor mutants retain wild-type receptors in the endoplasmic reticulum: molecular basis of the dominant-negative effect. , 2004, Molecular endocrinology.
[18] S. Mundlos,et al. Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux. , 2004, American journal of human genetics.
[19] K. Nakao,et al. Significance of C-type natriuretic peptide (CNP) in endochondral ossification: analysis of CNP knockout mice , 2002, Journal of Bone and Mineral Metabolism.
[20] G. Guruprasad,et al. Acromesomelic dysplasia of the maroteaux type , 1990, Indian journal of pediatrics.